Related Experiment Video
Updated: Apr 5, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma
Madhuri Bhandaru1, Magdalena Martinka2, Kevin J McElwee3
1Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
UV radiation induced genomic instability is one of the leading causes for melanoma. Phosphorylation of Ataxia Telangiectasia Mutated (ATM) is one of the initial events that follow DNA damage. Phospho-ATM (p-ATM) plays a key role in the activation of DNA repair and several oncogenic pathways as well as in the maintenance of genomic integrity. The present study was therefore performed to understand the significance of p-ATM in melanoma progression and to correlate it with patient prognosis. Tissue microarray and immunohistochemical analysis were employed to study the expression of p-ATM in melanoma patients. A total of 366 melanoma patients (230 primary melanoma and 136 metastatic melanoma) were used for the study. Chi-square test, Kaplan-Meier, univariate and multivariate Cox regression analysis were used to elucidate the prognostic significance of p-ATM expression. Results revealed that both loss of, and gain in, p-ATM expression were associated with progression of melanoma from normal nevi to metastatic melanoma. Patients whose samples showed negative or strong p-ATM staining had significantly worse 5-year survival compared to patients who had weak to moderate expression. Loss of p-ATM expression was associated with relatively better 5-year survival, but the corresponding 10-year survival curve almost overlapped with that of strong p-ATM expression. p-ATM expression was found to be an independent prognostic factor for 5-year but not for 10-year patient survival. In conclusion our findings show that loss of p-ATM expression and gain-in p-ATM expression are indicators of worse melanoma patient survival.
Insights
Altered expression of phospho-ATM (p-ATM), a key DNA damage response protein, is linked to melanoma progression. Both decreased and increased p-ATM levels indicate worse patient survival, highlighting its prognostic value in melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- UV radiation causes genomic instability, a primary driver of melanoma.
- Phosphorylation of Ataxia Telangiectasia Mutated (ATM) protein (p-ATM) is an early response to DNA damage.
- p-ATM is crucial for DNA repair, oncogenic pathway activation, and maintaining genomic integrity.
Purpose of the Study:
- To investigate the role of p-ATM in melanoma progression.
- To correlate p-ATM expression levels with patient prognosis in melanoma.
Main Methods:
- Tissue microarray and immunohistochemistry were used to analyze p-ATM expression in 366 melanoma patients.
- Statistical analyses included Chi-square tests, Kaplan-Meier, and Cox regression models.
- Patient cohorts comprised primary and metastatic melanoma cases.
Main Results:
- Both loss and gain of p-ATM expression correlated with melanoma progression from nevi to metastasis.
- Negative or strong p-ATM staining was associated with significantly worse 5-year survival compared to weak/moderate expression.
- p-ATM expression served as an independent prognostic factor for 5-year survival, but not 10-year survival.
Conclusions:
- Altered p-ATM expression (both loss and gain) is indicative of poorer melanoma patient survival.
- p-ATM status provides valuable prognostic information for melanoma patients, particularly for shorter-term survival.
- Further research may explore therapeutic strategies targeting ATM signaling in melanoma.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway

